1. Home
  2. MKTX vs RGEN Comparison

MKTX vs RGEN Comparison

Compare MKTX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarketAxess Holdings Inc.

MKTX

MarketAxess Holdings Inc.

HOLD

Current Price

$179.45

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$164.00

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKTX
RGEN
Founded
2000
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
8.2B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MKTX
RGEN
Price
$179.45
$164.00
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
$211.30
$174.90
AVG Volume (30 Days)
713.5K
552.2K
Earning Date
02-05-2026
02-19-2026
Dividend Yield
1.70%
N/A
EPS Growth
N/A
N/A
EPS
5.87
0.03
Revenue
$839,263,000.00
$707,890,000.00
Revenue This Year
$6.33
$17.84
Revenue Next Year
$8.10
$12.44
P/E Ratio
$30.41
$5,323.01
Revenue Growth
3.37
11.74
52 Week Low
$156.17
$102.97
52 Week High
$232.84
$182.52

Technical Indicators

Market Signals
Indicator
MKTX
RGEN
Relative Strength Index (RSI) 56.70 53.91
Support Level $181.22 $161.41
Resistance Level $184.39 $167.65
Average True Range (ATR) 2.45 4.61
MACD -0.08 -0.11
Stochastic Oscillator 33.12 68.88

Price Performance

Historical Comparison
MKTX
RGEN

About MKTX MarketAxess Holdings Inc.

Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: